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Cyclohexane is a volatile solvent used as a harmless substitute for dangerous organic
solvents in several products, such as paint thinners, gasoline and adhesives. Many of
these products are used as drugs of abuse and can severely damage neural tissue and
impair neurological functions. However, there is very little information on the effects of
cyclohexane on the brain. In humans, cyclohexane produces headaches, sleepiness,
dizziness, limb weakness, motor changes, and verbal memory impairment. Recent
studies in mice have demonstrated behavioral alterations, reactive gliosis, microglial
reactivity, and oxidative stress in the brains of cyclohexane-exposed animals. This
indicates that cyclohexanemay represent a potential problem for public health. Therefore,
studies are needed to clarify the neurobiological effects of this volatile compound,
including the cellular and molecular mechanisms of neurotoxicity, and to minimize the
human health risk posed by the intentional or accidental inhalation of this potential drug
of abuse.
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Inhalants are used as drugs of abuse by a large number of people globally. These substances are
found in numerous inexpensive and legally available commercial (thinners, gasoline, and adhesives,
etc.), which are widely available at supermarkets, workplaces, and online (Ridenour et al., 2007). In
the United States of America, approximately 5.2% of teenagers reported inhalant use at least once
in their lifetime (Johnston et al., 2014). The volatile compounds can be inhaled by various methods,
which are referred to as “sniffing,” “snorting,” “huffing,” and “bagging.” Typically, the duration of
inhalation is a few minutes (10–15min). However, during this period, a high concentration of
solvents (above 6000 ppm) can be inhaled, and this routine may be performed several times a day
(Bowen et al., 2006).
Inhalation of solvents has pernicious effects on the brain, produces severe systemic impairments,
and increases the risk of suicide and death (Ridenour et al., 2007). Solvent abuse can result in
neurological disorders, including psychiatric diseases such as depression, anxiety, bipolar mood
disorder, and addiction (Ridenour et al., 2007). The long-term exposure to organic solvents may
also produce chronic encephalopathy, which is characterized by abnormalities in brain structures
and cognitive dysfunction (Ramcharan et al., 2014).
Usually, commercial solvent abuse results in exposure to several volatile substances, such as
toluene, n-hexane, xylene and benzene. This makes it difficult to study the neurotoxic effects of the
individual constituents (Ramcharan et al., 2014). Therefore, researchers have to study the effects of
each solvent to clarify their role in brain degeneration and neurological impairment.
Cyclohexane is a volatile substance that has been implicated in cognitive deterioration (Bespalov
et al., 2003; Lammers et al., 2009). Initially, cyclohexane was considered a safe substitute for benzene
Campos-Ordonez and Gonzalez-Perez Cyclohexane and Neurodegeneration
FIGURE 1 | Behavioral and histological changes observed after cyclohexane inhalation in humans and rodents.
and toluene because of its lack of carcinogenic effects and low
toxicity (Sikkema et al., 1995; Yuasa et al., 1996). However,
cyclohexane is a strongly lipophilic molecule that can easily
diffuse through neural tissue and target numerous brain regions
(Figure 1). The effect of cyclohexane inhalation on the nervous
system was first evaluated in shoe workers. After a 6-h exposure
to low levels of this solvent, subjects develop dimmed vision
(Yasugi et al., 1994), sleepiness, dizziness, limb weakness,
sensorial disturbances (hypoesthesia and paresthesia), and motor
dysfunction of the median, ulnar and peroneal nerves (Mutti
et al., 1982; Yuasa et al., 1996). Volunteers exposed to a
moderate concentration of cyclohexane (250 ppm) reported a
higher incidence of headache, dry throat and verbal memory
impairment than subjects exposed to very low concentrations
of the compound (25 ppm; Lammers et al., 2009). In this
study by Lammers et al. (2009), the cyclohexane concentrations
corresponded to typical occupational exposure levels. However,
the effects of recreational doses of cyclohexane (often above 6000
ppm) remain unknown. Identifying the minimum concentration
of cyclohexane that produces neural degeneration would help
regulators set limits on the concentration of this solvent in
commercially available products.
The clinical features of solvent abusers include motor
impairment, euphoria, excitability, ataxia and depression.
Solvents such as toluene and trichloroethylene (TCE) exhibit
biphasic dose-response curves, characterized by motor excitation
at low exposure levels, and motor impairment, sedation and
anesthesia at high exposure levels (Bowen et al., 2006).
Interestingly, a similar biphasic dose-response effect has been
described in mice exposed to cyclohexane, and is associated
with neurohistological changes (Campos-Ordonez et al., 2015).
Furthermore, these volatile solvents produce dramatic structural
changes in the brain, including atrophy of the cerebral
cortex, white matter, corpus callosum, hippocampus, brainstem,
cerebellum, basal ganglia, red nuclei, and substantia nigra
(Fan et al., 2014; Ramcharan et al., 2014). Experimental
models of toluene, 1-bromopropane, TCE and dichloromethane
exposure have revealed the presence of astrocyte reactivity
and a microglial response in the hippocampus, cerebellum,
and cerebral cortex. The astroglial response to brain insults
is characterized by increased cell proliferation, hypertrophy,
and increased expression of glial fibrillary acidic protein
(GFAP; Gonzalez-Perez et al., 2015). In comparison, the
microglial response is characterized by dramatic morphological
changes that include a transition to an amoeboid morphology
and a reduction in cellular processes (Gonzalez-Perez et al.,
2012).
Cyclohexane at concentrations typical of those used by
recreational drug users (9000 ppm) also induces a glial cell
response in the hippocampus (Campos-Ordonez et al., 2015).
The astrocyte and microglial responses may have dual and
opposing effects on the CNS. These cells can be neuroprotective
because they secrete several neurotrophic factors and remove
toxins (Gonzalez-Perez et al., 2015). However, these cells can
also exert a neurotoxic effect because they secrete inflammatory
cytokines and produce nitric oxide and other reactive oxygen
Frontiers in Pharmacology | www.frontiersin.org 2 January 2016 | Volume 6 | Article 291
Campos-Ordonez and Gonzalez-Perez Cyclohexane and Neurodegeneration
species (ROS) that lead to neuronal damage and cell death
(Gonzalez-Perez et al., 2012).
Themolecular mechanisms that underlie the cytoarchitectural
alterations in the brain of solvent users are unclear.
However, a recent study found that cyclohexane promotes
the overexpression of AP endonuclease 1 (APE1) in the
hippocampus. This protein activates the cellular response to
oxidative stress and regulates the transcription of genes involved
in neuronal survival and DNA repair (Campos-Ordonez et al.,
2015). This suggests that cyclohexane perturbs the redox balance
in cells and affects the ability of tissue to detoxify ROS. The
accumulation of ROS causes cellular dysfunction by damaging
membranes, lipids, proteins, mitochondria, and DNA. However,
additional studies are needed to clarify the role of ROS in
cyclohexane-induced neurodegeneration.
The growing use of cyclohexane as a relatively safe
replacement for benzene or toluene in a myriad of commercial
products, including electronic cigarettes, necessitates a better
understanding of the biological effects of this solvent. Insight into
the cellular and molecular mechanisms of neural degeneration
induced by cyclohexane will help minimize the potential risk
associated with the intentional or accidental inhalation of this
volatile compound.
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